Sort
78,016 grants matching “breast cancer”
ELIMINATION OF THE NEUROCOGNITIVE DEFECTS FOLLOWING WHOLE BRAIN IRRADIATION FOR BREAST CANCER METASTASES
$783,116The Leland Stanford Junior University · · FY2015 · Department of Defense
Kansas Community Cancer Health Disparities Network
$783,101K Allen Greiner · University Of Kansas Medical Center · U54 · FY2013 · CA
Cellularly resolved molecular pathway assessment in biopsies via spectral imaging
$783,061Clifford C Hoyt · Cambridge Research And Instrumentation · R44 · FY2011 · CA
New Mexico Minority-Based Community Clinical Oncology Program
$783,029Melanie E Royce · University Of New Mexico · U10 · FY2010 · CA
Biobehavioral predictors of fatigue in newly-diagnosed breast cancer patients
$782,956Julienne E Bower · University Of California Los Angeles · R01 · FY2016 · CA
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE
$782,953Burnham Institute For Medical Research · R37 · FY2003 · CA
Steroid Hormone Genes and Ovarian Cancer Risk
$782,880Mary Anne Rossing · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Dynamics in the Tissue State: From Normal to Tumor and Back
$782,877Jan T. Liphardt · University Of California Berkeley · U54 · FY2012 · CA
Patterns of biological, cognitive, and physical aging in cancer survivors and controls and the role of sleep health: Relevance for Alzheimer's Disease and Related Dementias
$782,758Judith E Carroll · University Of California Los Angeles · R01 · FY2025 · AG
Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic
$782,520Aminah Jatoi · Mayo Clinic Rochester · K12 · FY2024 · CA
Bupropion for smoking cessation during pregnancy
$782,511Gary D Hankins · University Of Texas Med Br Galveston · R01 · FY2015 · DA
Increasing Access to Genetic Testing in Underserved Patients Using a Multilingual Conversational Agent
$782,502Charite Nicolette Ricker · University Of Southern California · R01 · FY2023 · CA
WMAT-JHU NARCH XI Application
$782,499Mariddie J Craig · White Mountain Apache Tribe · S06 · FY2023 · GM
Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers
$782,497Laura J Esserman · University Of California, San Francisco · U01 · FY2017 · CA
Lipid-based Nanocapsules and Triggered Chemotherapy
$782,351Robert Blumenthal · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Risk prediction methods
$782,343Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
Recombination and Regulation
$782,251Jeffrey Strathern · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Allele-specific gene expression and epigenetic information
$782,214Maxwell Lee · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Genomic targets of oncoproteins and tumor suppressors
$782,188Kevin Struhl · Harvard Medical School · R01 · FY2006 · CA
Leadership, Planning, and Evaluation
$782,071Gary K Schwartz · Case Western Reserve University · P30 · FY2024 · CA
Leadership, Planning, and Evaluation
$782,071Gary K Schwartz · Case Western Reserve University · P30 · FY2023 · CA
Hormonal Regulation of Breast Cancer
$781,755Jeffrey Rosen · Baylor College Of Medicine · R37 · FY2009 · CA
Antibody-guided localized activation of bioorthogonal protodrugs via click chemistry
$781,732Jose M Mejia Oneto · Shasqi, Inc. · R44 · FY2023 · CA
DNA Methylation: a Mechanism for Aggressive Breast Cancer in African-American Wom
$781,546Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2013 · CA
PRECISION ANTIBODY-BASED SYNERGISTIC DRUG COMBINATIONS FOR REFRACTORY TRIPLE-NEGATIVE BREAST CANCER
$781,530The General Hospital Corporation · · FY2021 · Department of the Army